Molecular, genetic, host-derived and clinical determinants of long-term survival in glioblastoma
The goal of this study is to better understand the contribution of (i) patient factors, (ii) tumor parameters, (iii) therapy and care and (iv) immunological parameters to prolonged survival in patients with glioblastoma.
Eligible participants are patients with glioblastoma that have survived for at least five years after diagnosis, and participation includes various clinical and neurocognitive assessments. We hope that this study will contribute to a better understanding of the natural history of glioblastoma, a comprehensive characterization of the molecular and physiological determinants of long-term survival, and the individual patient parameters that may affect disease course.
- Diagnosis of glioblastoma, with survival for at least five years from initial diagnosis
- Must have tumor tissue from original diagnostic surgery/biopsy available for central review